105 related articles for article (PubMed ID: 9059648)
21. The crystal structure of rat liver AKR7A1. A dimeric member of the aldo-keto reductase superfamily.
Kozma E; Brown E; Ellis EM; Lapthorn AJ
J Biol Chem; 2002 May; 277(18):16285-93. PubMed ID: 11839745
[TBL] [Abstract][Full Text] [Related]
22. Crystallographic analysis of a novel aldo-keto reductase from Thermotoga maritima in complex with NADP⁺.
Hou H; Li R; Wang X; Yuan Z; Liu X; Chen Z; Xu X
Acta Crystallogr F Struct Biol Commun; 2015 Jul; 71(Pt 7):847-55. PubMed ID: 26144229
[TBL] [Abstract][Full Text] [Related]
23. Structure of aldehyde reductase in ternary complex with coenzyme and the potent 20alpha-hydroxysteroid dehydrogenase inhibitor 3,5-dichlorosalicylic acid: implications for inhibitor binding and selectivity.
Carbone V; Chung R; Endo S; Hara A; El-Kabbani O
Arch Biochem Biophys; 2008 Nov; 479(1):82-7. PubMed ID: 18782556
[TBL] [Abstract][Full Text] [Related]
24. The structure of human aldose reductase bound to the inhibitor IDD384.
Calderone V; Chevrier B; Van Zandt M; Lamour V; Howard E; Poterszman A; Barth P; Mitschler A; Lu J; Dvornik DM; Klebe G; Kraemer O; Moorman AR; Moras D; Podjarny A
Acta Crystallogr D Biol Crystallogr; 2000 May; 56(Pt 5):536-40. PubMed ID: 10771421
[TBL] [Abstract][Full Text] [Related]
25. The crystallographic structure of the aldose reductase-IDD552 complex shows direct proton donation from tyrosine 48.
Ruiz F; Hazemann I; Mitschler A; Joachimiak A; Schneider T; Karplus M; Podjarny A
Acta Crystallogr D Biol Crystallogr; 2004 Aug; 60(Pt 8):1347-54. PubMed ID: 15272156
[TBL] [Abstract][Full Text] [Related]
26. Structure of human aldose reductase holoenzyme in complex with statil: an approach to structure-based inhibitor design of the enzyme.
El-Kabbani O; Ramsland P; Darmanin C; Chung RP; Podjarny A
Proteins; 2003 Feb; 50(2):230-8. PubMed ID: 12486717
[TBL] [Abstract][Full Text] [Related]
27. The Effect of Halogen-to-Hydrogen Bond Substitution on Human Aldose Reductase Inhibition.
Fanfrlík J; Ruiz FX; Kadlčíková A; Řezáč J; Cousido-Siah A; Mitschler A; Haldar S; Lepšík M; Kolář MH; Majer P; Podjarny AD; Hobza P
ACS Chem Biol; 2015 Jul; 10(7):1637-42. PubMed ID: 25919404
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of 3(17)alpha-hydroxysteroid dehydrogenase (AKR1C21) by aldose reductase inhibitors.
Dhagat U; Endo S; Hara A; El-Kabbani O
Bioorg Med Chem; 2008 Mar; 16(6):3245-54. PubMed ID: 18165015
[TBL] [Abstract][Full Text] [Related]
29. The structure of human recombinant aldose reductase complexed with the potent inhibitor zenarestat.
Kinoshita T; Miyake H; Fujii T; Takakura S; Goto T
Acta Crystallogr D Biol Crystallogr; 2002 Apr; 58(Pt 4):622-6. PubMed ID: 11914486
[TBL] [Abstract][Full Text] [Related]
30. Mechanism of human aldehyde reductase: characterization of the active site pocket.
Barski OA; Gabbay KH; Grimshaw CE; Bohren KM
Biochemistry; 1995 Sep; 34(35):11264-75. PubMed ID: 7669785
[TBL] [Abstract][Full Text] [Related]
31. Merging the binding sites of aldose and aldehyde reductase for detection of inhibitor selectivity-determining features.
Steuber H; Heine A; Podjarny A; Klebe G
J Mol Biol; 2008 Jun; 379(5):991-1016. PubMed ID: 18495158
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of aldose reductase inhibition and docking studies of some secondary metabolites, isolated from Origanum vulgare L. ssp. hirtum.
Koukoulitsa C; Zika C; Geromichalos GD; Demopoulos VJ; Skaltsa H
Bioorg Med Chem; 2006 Mar; 14(5):1653-9. PubMed ID: 16249088
[TBL] [Abstract][Full Text] [Related]
33. Structure and characterization of a NAD(P)H-dependent carbonyl reductase from Pseudomonas aeruginosa PAO1.
Li S; Teng X; Su L; Mao G; Xu Y; Li T; Liu R; Zhang Q; Wang Y; Bartlam M
FEBS Lett; 2017 Jun; 591(12):1785-1797. PubMed ID: 28524228
[TBL] [Abstract][Full Text] [Related]
34. Identification of a novel polyfluorinated compound as a lead to inhibit the human enzymes aldose reductase and AKR1B10: structure determination of both ternary complexes and implications for drug design.
Cousido-Siah A; Ruiz FX; Mitschler A; Porté S; de Lera ÁR; Martín MJ; Manzanaro S; de la Fuente JA; Terwesten F; Betz M; Klebe G; Farrés J; Parés X; Podjarny A
Acta Crystallogr D Biol Crystallogr; 2014 Mar; 70(Pt 3):889-903. PubMed ID: 24598757
[TBL] [Abstract][Full Text] [Related]
35. Aldose reductase activation is a key component of myocardial response to ischemia.
Hwang YC; Sato S; Tsai JY; Yan S; Bakr S; Zhang H; Oates PJ; Ramasamy R
FASEB J; 2002 Feb; 16(2):243-5. PubMed ID: 11772943
[TBL] [Abstract][Full Text] [Related]
36. Identification of a determinant for strict NADP(H)-specificity and high sensitivity to mixed-type steroid inhibitor of rabbit aldo-keto reductase 1C33 by site-directed mutagenesis.
Endo S; Matsunaga T; Ikari A; El-Kabbani O; Hara A; Kitade Y
Arch Biochem Biophys; 2015 Mar; 569():19-25. PubMed ID: 25660042
[TBL] [Abstract][Full Text] [Related]
37. Site-directed mutagenesis of residues in coenzyme-binding domain and active site of mouse lung carbonyl reductase.
Nakanishi M; Kaibe H; Matsuura K; Kakumoto M; Tanaka N; Nonaka T; Mitsui Y; Hara A
Adv Exp Med Biol; 1997; 414():555-61. PubMed ID: 9059662
[No Abstract] [Full Text] [Related]
38. Synthesis of novel benzoic acid derivatives with benzothiazolyl subunit and evaluation as aldose reductase inhibitors.
Rakowitz D; Hennig B; Nagano M; Steger S; Costantino L; Matuszczak B
Arch Pharm (Weinheim); 2005 Sep; 338(9):411-8. PubMed ID: 16143954
[TBL] [Abstract][Full Text] [Related]
39. Probing flexibility and "induced-fit" phenomena in aldose reductase by comparative crystal structure analysis and molecular dynamics simulations.
Sotriffer CA; Krämer O; Klebe G
Proteins; 2004 Jul; 56(1):52-66. PubMed ID: 15162486
[TBL] [Abstract][Full Text] [Related]
40. Aldose reductase inhibition protects diabetic and nondiabetic rat hearts from ischemic injury.
Ramasamy R; Oates PJ; Schaefer S
Diabetes; 1997 Feb; 46(2):292-300. PubMed ID: 9000707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]